HIGHLIGHTS
SUMMARY
This cohort included all the patients who benefited from HCCP applications between 2014 and 2018 for peripheral neuropathic pain. The CERCAN cohort was constituted by including all the patients who had benefited from HCCP applications at the ICO between 1 January 2014 and 31 December 2018 for neuropathic pain whether or not it was related to their cancer. Exclusion criteria included an HCCP application starting before 31 December 2013 and HCCP applications for neuropathic pain not related to CIPN. The data were censored on 22 December 2021, while 15 patients were still being treated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.